- Home
- AUUD vs CNSP Comparison
AUUD vs CNSP Comparison
Compare AUUD & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- CNSP
- Stock Information
- Founded
- AUUD 2012
- CNSP 2017
- Country
- AUUD United States
- CNSP United States
- Employees
- AUUD N/A
- CNSP N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- CNSP Health Care
- Exchange
- AUUD Nasdaq
- CNSP Nasdaq
- Market Cap
- AUUD 4.1M
- CNSP 4.0M
- IPO Year
- AUUD 2021
- CNSP 2019
- Fundamental
- Price
- AUUD $0.94
- CNSP $7.20
- Analyst Decision
- AUUD
- CNSP Strong Buy
- Analyst Count
- AUUD 0
- CNSP 1
- Target Price
- AUUD N/A
- CNSP $20.00
- AVG Volume (30 Days)
- AUUD 71.0K
- CNSP 13.8K
- Earning Date
- AUUD 11-06-2025
- CNSP 11-17-2025
- Dividend Yield
- AUUD N/A
- CNSP N/A
- EPS Growth
- AUUD N/A
- CNSP N/A
- EPS
- AUUD N/A
- CNSP N/A
- Revenue
- AUUD N/A
- CNSP N/A
- Revenue This Year
- AUUD N/A
- CNSP N/A
- Revenue Next Year
- AUUD N/A
- CNSP N/A
- P/E Ratio
- AUUD N/A
- CNSP N/A
- Revenue Growth
- AUUD N/A
- CNSP N/A
- 52 Week Low
- AUUD $0.84
- CNSP $4.93
- 52 Week High
- AUUD $14.60
- CNSP $114.00
- Technical
- Relative Strength Index (RSI)
- AUUD 29.89
- CNSP 46.98
- Support Level
- AUUD $0.84
- CNSP $6.30
- Resistance Level
- AUUD $1.10
- CNSP $7.07
- Average True Range (ATR)
- AUUD 0.08
- CNSP 0.59
- MACD
- AUUD 0.01
- CNSP 0.06
- Stochastic Oscillator
- AUUD 28.46
- CNSP 34.80
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.